CXCL8 and acute respiratory distress syndrome: However, treatments targeting specific anti-cytokines (e.g., anti-TNF-α and IL-8 antibody) for ALI/ARDS mitigated over-exuberant cytokine activity were not successful (Raghavendran et al., 2008).